ICSMA-20-079-01
Vulnerability from csaf_cisa
Published
2020-03-19 00:00
Modified
2020-03-19 00:00
Summary
Insulet Omnipod

Notes

CISA Disclaimer
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
Legal Notice
All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Risk evaluation
Successful exploitation of this vulnerability may allow an attacker to gain access to the affected products to intercept, modify, or interfere with the wireless RF (radio frequency) communications to or from the product. This may allow attackers to read sensitive data, change pump settings, or control insulin delivery.
Critical infrastructure sectors
Healthcare and Public Health
Countries/areas deployed
United States, Canada, Europe
Company headquarters location
United States
Recommended Practices
CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:
Recommended Practices
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures. CISA also provides a section for control systems security recommended practices on the ICS webpage onus-cert.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Recommended Practices
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies. Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.
Recommended Practices
This vulnerability is not exploitable remotely.


To clipboard 

{
  "document": {
    "acknowledgments": [
      {
        "organization": "Thirdwayv Inc",
        "summary": "reporting this vulnerability to Insulet"
      },
      {
        "organization": "Insulet",
        "summary": "reporting this vulnerability to CISA"
      }
    ],
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "general",
        "text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
        "title": "CISA Disclaimer"
      },
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "summary",
        "text": "Successful exploitation of this vulnerability may allow an attacker to gain access to the affected products to intercept, modify, or interfere with the wireless RF (radio frequency) communications to or from the product. This may allow attackers to read sensitive data, change pump settings, or control insulin delivery.",
        "title": "Risk evaluation"
      },
      {
        "category": "other",
        "text": "Healthcare and Public Health",
        "title": "Critical infrastructure sectors"
      },
      {
        "category": "other",
        "text": "United States, Canada, Europe",
        "title": "Countries/areas deployed"
      },
      {
        "category": "other",
        "text": "United States",
        "title": "Company headquarters location"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.\nCISA also provides a section for control systems security recommended practices on the ICS webpage onus-cert.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.\nOrganizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "This vulnerability is not exploitable remotely.",
        "title": "Recommended Practices"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-20-079-01 JSON",
        "url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2020/icsma-20-079-01.json"
      },
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-20-079-01 Web Version",
        "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-20-079-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.fda.gov/medical-devices/digital-health/cybersecurity"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.us-cert.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.us-cert.gov/ics/tips/ICS-TIP-12-146-01B"
      }
    ],
    "title": "Insulet Omnipod",
    "tracking": {
      "current_release_date": "2020-03-19T00:00:00.000000Z",
      "generator": {
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSMA-20-079-01",
      "initial_release_date": "2020-03-19T00:00:00.000000Z",
      "revision_history": [
        {
          "date": "2020-03-19T00:00:00.000000Z",
          "legacy_version": "Initial",
          "number": "1",
          "summary": "ICSMA-20-079-01 Insulet Omnipod"
        }
      ],
      "status": "final",
      "version": "1"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version",
                "name": "UDI/Model/NDC number ZXP425 (10-Pack) | ZXR425 (10-Pack Canada)",
                "product": {
                  "name": "Omnipod Insulin Management System: UDI/Model/NDC number ZXP425 (10-Pack) and ZXR425 (10-Pack Canada)",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "Omnipod Insulin Management System"
          },
          {
            "branches": [
              {
                "category": "product_version",
                "name": "Product ID/Reorder number 19191 | 40160",
                "product": {
                  "name": "Omnipod Insulin Management System: Product ID/Reorder number 19191 and 40160",
                  "product_id": "CSAFPID-0002"
                }
              }
            ],
            "category": "product_name",
            "name": "Omnipod Insulin Management System"
          }
        ],
        "category": "vendor",
        "name": "Insulet"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2020-10627",
      "cwe": {
        "id": "CWE-284",
        "name": "Improper Access Control"
      },
      "notes": [
        {
          "category": "summary",
          "text": "The affected insulin pump is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.CVE-2020-10627has been assigned to this vulnerability. A CVSS v3 base score of 7.3 has been assigned; the CVSS vector string is (AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L).",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "web.nvd.nist.gov",
          "url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-10627"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L"
        }
      ],
      "remediations": [
        {
          "category": "vendor_fix",
          "details": "Insulet recommends patients using the affected products talk to their healthcare provider about the risks of continued use, including the possibility of changing to the latest model with increased cybersecurity protection.\nAdditionally, Insulet recommends all patients take the cybersecurity precautions indicated below.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        },
        {
          "category": "vendor_fix",
          "details": "Insulet has released additional patient-focused information.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.myomnipod.com/security-bulletins"
        },
        {
          "category": "vendor_fix",
          "details": "More information is available regarding Insulet \u0027s product security and vulnerability management.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ],
          "url": "https://www.myomnipod.com/product-security"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 7.3,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.0/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002"
          ]
        }
      ]
    }
  ]
}


Log in or create an account to share your comment.




Tags
Taxonomy of the tags.




Sightings

Author Source Type Date

Nomenclature

  • Seen: The vulnerability was mentioned, discussed, or seen somewhere by the user.
  • Confirmed: The vulnerability is confirmed from an analyst perspective.
  • Published Proof of Concept: A public proof of concept is available for this vulnerability.
  • Exploited: This vulnerability was exploited and seen by the user reporting the sighting.
  • Patched: This vulnerability was successfully patched by the user reporting the sighting.
  • Not exploited: This vulnerability was not exploited or seen by the user reporting the sighting.
  • Not confirmed: The user expresses doubt about the veracity of the vulnerability.
  • Not patched: This vulnerability was not successfully patched by the user reporting the sighting.